Gary J Nabel
Overview
Explore the profile of Gary J Nabel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
242
Citations
21681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joyce M, Bu W, Chen W, Gillespie R, Andrews S, Wheatley A, et al.
Immunity
. 2025 Feb;
58(2):295-308.e5.
PMID: 39909035
Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with malignancies in humans. Viral infection of B cells is initiated by the viral glycoprotein 350 (gp350) binding to complement receptor...
2.
Misasi J, Wei R, Wang L, Pegu A, Wei C, Oloniniyi O, et al.
Sci Transl Med
. 2024 Oct;
16(768):eado9026.
PMID: 39383243
Despite effective countermeasures, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists worldwide because of its ability to diversify and evade human immunity. This evasion stems from amino acid substitutions, particularly...
3.
Promsote W, Xu L, Hataye J, Fabozzi G, March K, Almasri C, et al.
Nat Commun
. 2023 Jun;
14(1):3719.
PMID: 37349337
Agents that can simultaneously activate latent HIV, increase immune activation and enhance the killing of latently-infected cells represent promising approaches for HIV cure. Here, we develop and evaluate a trispecific...
4.
Cable J, Balachandran S, Daley-Bauer L, Rustagi A, Antony F, Frere J, et al.
Ann N Y Acad Sci
. 2023 Jan;
1521(1):32-45.
PMID: 36718537
Viruses infect millions of people each year. Both endemic viruses circulating throughout the population as well as novel epidemic and pandemic viruses pose ongoing threats to global public health. Developing...
5.
Hunegnaw R, Honko A, Wang L, Carr D, Murray T, Shi W, et al.
Sci Transl Med
. 2022 Dec;
14(675):eabq6364.
PMID: 36516269
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent...
6.
Misasi J, Wei R, Wang L, Pegu A, Wei C, Oloniniyi O, et al.
bioRxiv
. 2022 Aug;
PMID: 35982683
Despite effective countermeasures, SARS-CoV-2 persists worldwide due to its ability to diversify and evade human immunity. This evasion stems from amino-acid substitutions, particularly in the receptor-binding domain of the spike,...
7.
Rainho-Tomko J, Pavot V, Kishko M, Swanson K, Edwards D, Yoon H, et al.
NPJ Vaccines
. 2022 Jun;
7(1):74.
PMID: 35773301
Respiratory syncytial virus (RSV) G glycoprotein has recently reemerged as a vaccine antigen due to its ability to elicit potent neutralizing antibodies and ameliorate disease in animal models. Here we...
8.
Wei C, Bu W, Nguyen L, Batchelor J, Kim J, Pittaluga S, et al.
Sci Transl Med
. 2022 May;
14(643):eabf3685.
PMID: 35507671
Epstein-Barr virus (EBV) is the major cause of infectious mononucleosis and is associated with several human cancers and, more recently, multiple sclerosis. Despite its prevalence and health impact, there are...
9.
Casazza J, Cale E, Narpala S, Yamshchikov G, Coates E, Hendel C, et al.
Nat Med
. 2022 Apr;
28(5):1022-1030.
PMID: 35411076
Adeno-associated viral vector-mediated transfer of DNA coding for broadly neutralizing anti-HIV antibodies (bnAbs) offers an alternative to attempting to induce protection by vaccination or by repeated infusions of bnAbs. In...
10.
Seung E, Xing Z, Wu L, Rao E, Cortez-Retamozo V, Ospina B, et al.
Nature
. 2022 Mar;
604(7905):E13.
PMID: 35332336
No abstract available.